filmov
tv
Advanced/Metastatic Gastric Cancer: Beyond Frontline
Показать описание
Alan P. Venook, MD; Yelena Y. Janjigian, MD; and Zev A. Wainberg, MD, outline the best practices in treating advanced or metastatic gastric and GEJ cancers beyond the first line of therapy.
0:05:40
Advanced/Metastatic Gastric Cancer: Beyond Frontline
0:04:12
Metastatic Gastric Cancer: Factors in Selecting Frontline Therapy
0:04:50
Metastatic Gastric Cancer: Promising Frontline Trials
0:02:10
Advances in the treatment of peritoneal metastases in gastric cancer
0:07:26
Is Frontline IO Therapy Appropriate in Gastric Cancer?
0:07:59
Metastatic Gastric Cancer: Promising Later-Line Trials
0:20:04
Metastatic gastric cancer: New targeted agents in metastatic gastric cancer
0:05:34
Metastatic Gastric Cancer: Identifying Disease Progression
0:07:02
Later Lines of Therapy in Metastatic Gastric Cancer
0:00:28
Stomach Cancer Stages and Survival Rate | #MCAShorts
0:15:19
2021 International Gastric Cancer Educational Symposium - Treatments for Metastatic Gastric Cancer
0:03:15
Pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
0:10:54
Metastatic gastric cancer: Indications and impact of angiogenesis inhibitors
0:01:31
Optimal Supportive Care for Metastatic Gastric Cancer
0:09:36
MIS as a treatment option for gastric cancer with liver metastasis: A comparison with open surgery
0:09:29
Sara's Gift - A Legacy of Hope for Gastric Cancer Patients
0:05:06
Treating Unresectable or Metastatic Gastric/GEJ Cancers
0:10:06
Personalizing the Management of Advanced Gastric Cancer
0:10:16
Ongoing Research in Gastric Cancer; Antiangiogenic Therapy Upfront and Immunotherapy
0:05:40
Up-front Treatment of Metastatic Gastroesophageal Cancer
0:10:03
Guidelines for Metastatic Frontline Therapy in GEC
0:05:01
HER2+ Gastric Cancer
0:05:17
MSI Testing’s Impact on Immunotherapy in Gastric Cancers
0:05:42
Evolving Global Treatment Landscape for Gastric Cancer
Комментарии